Tadalafil Enhances Immune Signatures in Response to Neoadjuvant Nivolumab in Resectable Head and Neck Squamous Cell Carcinoma - Luginbuhl, A J; Johnson, J M; Harshyne, L A (Clin Cancer Res, 2022)